SOURCE: Atomera Incorporated

November 06, 2017 16:05 ET

Atomera Incorporated Provides Third Quarter Update

LOS GATOS, CA--(Marketwired - Nov 6, 2017) - Atomera Incorporated ("Atomera" or the "Company") (NASDAQ: ATOM), a semiconductor materials and intellectual property licensing company focused on deploying its proprietary technology into the semiconductor industry, today provided a corporate update and announced results for the third quarter ended September 30, 2017.

Third Quarter Highlights

  • Atomera announced a new customer entering trials, which increases the number of potential customers in the pivotal integration phase to five.
  • 13 total customers are now engaged with Atomera with two new additions since last quarter.
  • Synopsys' latest release of its market-leading TCAD software now supports modeling Atomera's MST technology.
  • Participated in marketing roadshow with Synopsys showcasing the simulation of MST.

Management Commentary

"Our third quarter showed significant increases in customer activity, both with new trials and earlier phase engagement. Atomera's new Synopsys TCAD capability is generating strong industry enthusiasm and helping to shorten our time to revenue," commented Scott Bibaud, President and CEO.

Third Quarter Financial Results

During the third quarter of 2017, the Company incurred a net loss of $3.3 million, or ($0.27) per share, compared to a net loss of $3.6 million, or ($0.30) per share, in the second quarter of 2017, and a net loss of $4.1 million, or ($0.56) per share, for the third quarter of 2016. Adjusted EBITDA (a non-GAAP financial measure) in the third quarter of 2017 was a loss of $2.4 million compared to an adjusted EBITDA loss in the second quarter of 2017 of $2.2 million, and an adjusted EBITDA loss of $1.7 million in the third quarter of 2016. 

The Company had $19.6 million in cash and cash equivalents as of September 30, 2017, compared to $21.7 million as of June 30, 2017.

The total number of shares outstanding was 12,160,637 as of September 30, 2017.

Third Quarter 2017 Conference Call and Webcast

Atomera will host a conference call to discuss its financial results and recent progress. Date: Monday, November 6, 2017

Time: 1:30 p.m. PT (4:30 p.m. ET)
Phone: (844) 263-8318 (domestic); +1 (213) 358-0960 (international)
Replay: Available until November 13, 2017 (855) 859-2056 (domestic); +1(404) 537-3406 (international); passcode 96537935.
Webcast: Accessible at www.atomera.com

Note about NonGAAP Financial Measures

In addition to the unaudited results presented in accordance with generally accepted accounting principles, or GAAP, in this press release, Atomera presents adjusted EBITDA, which is a nonGAAP financial measure. Adjusted EBITDA is determined by taking net loss and eliminating the impacts of interest, taxes, depreciation, amortization, stockbased compensation and the change in fair value of derivative liabilities. Our definition of adjusted EBITDA may not be comparable to the definitions of similarlytitled measures used by other companies. We believe that this nonGAAP financial measure, viewed in addition to and not in lieu of its reported GAAP results, provides useful information to investors by providing a more focused measure of operating results. This metric is used as part of the Company's internal reporting to evaluate its operations and the performance of senior management. A table reconciling this measure to the comparable GAAP measure is available in the accompanying financial tables below.

About Atomera Incorporated

Atomera Incorporated has developed Mears Silicon Technology™ ("MST®"), which increases performance and power efficiency in semiconductor transistors. MST® can be implemented using equipment already deployed in semiconductor manufacturing facilities and is complementary to other nanoscaling technologies already in the semiconductor industry roadmap.

Safe Harbor

This press release contains forwardlooking statements concerning Atomera Incorporated, including statements regarding the prospects for the semiconductor industry generally and the ability of our MST® technology to significantly improve semiconductor performance. Those forwardlooking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially. Among those factors are: (1) the fact that we have not yet commenced revenue producing operations or entered into a definitive agreement with regard to the licensing or commercialization of our MST technology, thus subjecting us to all of the risks inherent in a prerevenue enterprise; (2) risks related to our ability to raise sufficient capital, as and when needed, to pursue the further development, licensing and commercialization of our MST® technology; (3) our ability to protect our proprietary technology, trade secrets and knowhow, and (4) those other risks disclosed in the section "Risk Factors" included in our Annual Report on Form 10-K for the year ended December 31, 2016 filed with the SEC on March 31, 2017. We caution readers not to place undue reliance on any forwardlooking statements. We do not undertake, and specifically disclaim any obligation, to update or revise such statements to reflect new circumstances or unanticipated events as they occur.

   
Atomera Incorporated  
Condensed Balance Sheets  
(in thousands, except per share data)  
   
    September 30,     December 31,  
    2017     2016  
    (Unaudited)        
             
ASSETS                
                 
Current assets:                
  Cash and cash equivalents   $ 19,606     $ 26,718  
  Prepaid expenses and other current assets     132       96  
    Total current assets     19,738       26,814  
                 
Property and equipment, net     31       28  
Security deposit     37       37  
                 
    Total assets   $ 19,806     $ 26,879  
                 
LIABILITIES AND STOCKHOLDERS' EQUITY                
                 
Current liabilities:                
  Accounts payable   $ 286     $ 353  
  Accrued expenses     299       168  
  Accrued payroll related expenses     277       510  
                 
    Total liabilities     862       1,031  
                 
    Commitments and contingencies                
                 
Stockholders' equity:                
  Preferred stock, $0.001 par value, authorized 2,500 shares; none issued and outstanding at September 30, 2017 and December 31, 2016     -       -  
  Common stock, $0.001 par value, authorized 47,500 shares; 12,161 shares issued and outstanding at September 30, 2017 and 12,025 issued and outstanding as of December 31, 2016     12       12  
  Additional paid-in capital     125,387       121,833  
  Accumulated deficit     (106,455 )     (95,997 )
    Total stockholders' equity     18,944       25,848  
                 
Total liabilities and stockholders' equity   $ 19,806     $ 26,879  
                 
   
Atomera Incorporated  
Condensed Statements of Operations  
(Unaudited)  
(in thousands, except per share data)  
   
    Three Months ended
September 30,
    Nine Months ended
September 30,
 
    2017     2016     2017     2016  
Operating expenses:                                
  Research and development   $ 1,602     $ 941     $ 4,502     $ 2,757  
  General and administrative     1,374       1,613       4,689       3,369  
  Selling and marketing     350       229       1,367       439  
    Total operating expenses     3,326       2,783       10,558       6,565  
                                 
    Loss from operations     (3,326 )     (2,783 )     (10,558 )     (6,565 )
                                 
Other income/(expense):                                
  Interest income     42       6       106       8  
  Interest expense     -       (1,330 )     -       (2,640 )
  Other expense     -       -       (6 )     -  
    Total other income / (expense), net     42       (1,324 )     100       (2,632 )
                                 
Net loss   $ (3,284 )   $ (4,107 )   $ (10,458 )   $ (9,197 )
                                 
Net loss per common share, basic and diluted   $ (0.27 )   $ (0.56 )   $ (0.86 )   $ (2.59 )
                                 
Weighted average number of common shares outstanding, basic and diluted     12,161       7,382       12,111       3,553  
                                 
   
Atomera Incorporated  
Reconciliation to Non-GAAP Adjusted EBITDA  
(Unaudited)  
(in thousands)  
   
    Three Months ended
September 30,
    Six Months ended
September 30,
 
    2017     2016     2017     2016  
                         
Net loss (GAAP):   $ (3,284 )   $ (4,107 )   $ (10,458 )   $ (9,197 )
Add (subtract) the following items:                                
  Interest income     (42 )     (6 )     (106 )     (8 )
  Interest expense     --       1,330       --       2,640  
  Depreciation and amortization     4       4       13       10  
  Stock-based compensation     916       1,031       3,554       1,140  
Adjusted EBITDA (non-GAAP)   $ (2,406 )   $ (1,748 )   $ (6,997 )   $ (5,415 )
                                 

Contact Information